Lisa Wang

Use and misuse of waterfall plots.

Tiffany Shao, Lisa Wang, Arnoud J Templeton, 2014, Journal of the National Cancer Institute.

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

Celeste Yu, Lisa Wang, Suzanne Kamel-Reid, 2017, Breast Cancer Research and Treatment.

A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer

Joseph L. Chin, John Trachtenberg, Lisa Wang, 2010, American journal of clinical oncology.

Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.

Lisa Wang, Levon M Khachigian, L. Khachigian, 2010, Biochemical and biophysical research communications.

TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses

Igor Jurisica, Chiara Pastrello, Katherine Karakasis, 2019, International Journal of Gynecologic Cancer.

Potential drug interactions in cancer patients receiving supportive care exclusively.

Lisa Wang, R. Riechelmann, M. Krzyzanowska, 2008, Journal of pain and symptom management.

Potential drug interactions and duplicate prescriptions among cancer patients.

Lisa Wang, Ian F Tannock, I. Tannock, 2007, Journal of the National Cancer Institute.

Reporting of serious adverse drug reactions of targeted anticancer agents in pivotal phase III clinical trials.

Lisa Wang, Ian F Tannock, I. Tannock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial

Carl Virtanen, Mahadeo A. Sukhai, Trevor J. Pugh, 2016, Genome Medicine.